Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepitel Film for Radiotherapy Skin Toxicity in Breast Cancer
NCT02741258Phase 3Completed
- Start
- Oct 2015
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms). Primary endpoint: Mepitel Film efficacy in treating skin toxicity evaluated with Common Terminology Criteria for Adverse Events (CTCAE). Started Oct 2015; status: completed.
Beyond the preview
Go deeper on NCT02741258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02741258.